NCT01333644View on ClinicalTrials.gov

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
HIV InfectionCardiovascular DiseaseInflammation
Trial Locations (1)

94110

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT01333644 - The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk | Biotech Hunter | Biotech Hunter